Abstract
Quality by design (QbD) may aid in all three stages of product development, from conceptualization through fabrication to final assembly. The Food and Drug Administration has given QbD in the healthcare industry high priority in order to better explain manufacturing processes, based on a complete understanding of how technology and design variables effect quality in production. Quality by design (CPD) encompasses CQA, CMA, and CPP, or critical quality, critical material, and critical process aspects, respectively. Among the many tools utilized in Quality by Design (QbD) are risk analysis, experimental design, and process analytical technologies. The QbD approach has several advantages, including less experimentation, increased productivity, and the elimination of sample mistakes and unpredictability in scientific investigations. Use of QbD techniques in such inquiries may intelligently finish the research procedures, since evaluating microparticles and nanotechnology-based formulations requires specialized equipment and a lengthy process.
Keywords
microparticles, nanotechnology, Quality, healthcare, manufacturing, Risk